PROM1 and neoplasm: Our other study provided the inhibitory mechanism of EGCG on tumor angiogenesis, including the inhibition of TEC migration toward VEGF, inhibition of EGCG‐mediated Akt phosphorylation in TECs, and the suppression of VEGF‐induced mobilization of CD133+/VEGFR2+ cells into the peripheral circulation [9].